Molefy Pharma is a biotech spin off dedicated to pioneering groundbreaking treatments for neurodegenerative diseases.
Our mission is to develop a treatment capable of halting the progression of the disease, not just slowing it down, and bringing real hope to patients and their families.
At Molefy Pharma, we are dedicated to developing innovative treatments that offer real hope to patients.
Our goal is clear: to develop a therapy capable of halting the progression of the disease, slowing its advance, and limiting the neurological deterioration associated with ALS.
Backed by scientific excellence and a deep commitment to those living with the disease, we work to make a lasting impact.
We strive to push the boundaries of biotechnology with every step we take, while always keeping the needs of ALS patients at the heart of our work.
Seeking a cure for ALS